CClinicalTrials.gg
CompletedNCT02307136SUREAUpdated Feb 17, 2016

Evaluation of the Impact of Within-hospital Trajectories of Patients Admitted in Intensive Care Units (ICU) From Emergency Departments

An observational study in Intensive Care Units and Emergency Department, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-02-17.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
50,000
Ages
18 Years and older
Sex
All
01

Study summary

This multicenter cohort aims to assess the impact of within-hospital trajectories of patients admitted in intensive care units from emergency departments on vital prognosis of patients, duration of hospital stay and hospital costs.

As secondary objectives, the study will:

  • assess the impact of clinical and demographic characteristics on hospital trajectories of patients.
  • assess the impact of emergency units workload, beds availability in medical units and in intensive care units, and global hospital organisation on patients care trajectories.
Read the detailed description

The study will be performed in emergency departments and ICUs of university hospitals. 15 emergency departments and 36 ICUs of APHP (the public hospital system of the city of Paris) will be involved.

The study will assemble the data from 50,000 to 80,000 patients in total.

Eligible patients are admitted in ICUs between 01/01/2007 and 12/31/2011.

Extraction of the patients' data will be performed with processing software utilised in APHP, i.e. Healthcare Information System Program (PMSI, Urqual, Gilda...etc.).

Collected patients' data span the period from admission in emergency department or medical department unitl hospital discharge.

02

Conditions studied

  • Intensive Care Units
  • Emergency Department

Browse trials for

Keywords

  • intensive care units
  • emergency department
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 50,000 is above the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The population under study is formed of patients admitted in 3 types of intensive care units (Medical intensive care unit, Surgical Intensive Care Unit and Cardiac Intensive Care Unit), transferred from emergency departments, either directly, or from another Department such as a Unit of short durations of hospitalization.

Inclusion criteria

  • Adult patient directly admitted in ICU from emergency departments of APHP (the public hospital system of the city of Paris).
  • Adult patient indirectly transferred to ICU from an hospitalization unit, initially admitted from an emergency department of APHP.

Exclusion criteria

Exclusion Criteria:

  • Patient transferred from APHP toward an external hospital, outside APHP, before being admitted in an ICU.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
50,000 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Mortality

    Mortality in ICU and in other hospital units

    Time frame: throughout the study: 5 years

  2. Rate of direct transfer

    Rate of direct transfer from Emergency Unit to ICU

    Time frame: throughout the study: 5 years

  3. Rate of indirect transfer

    Rate of indirect transfer from a hospitalization Unit to ICU

    Time frame: throughout the study: 5 years

  4. Duration of stay in emergency department, in ICU and in hospital

    Duration of stay in emergency department, in ICU and in hospital

    Time frame: throughout the study: 5 years

  5. Mode of discharge from ICU

    Mode of discharge from ICU and direction of patient (home, other structures etc.)

    Time frame: throughout the study: 5 years

Secondary outcomes

  1. Severity scores

    Severity scores in ICU

    Time frame: throughout the study: 5 years

  2. Use and duration of mechanical ventilation

    Use and duration of mechanical ventilation for patient during ICU stay

    Time frame: throughout the study: 5 years

  3. Score of burden of care in ICU

    Score of burden of care in ICU

    Time frame: throughout the study: 5 years

  4. Percentage of patients with ICU stay

    Percentage of patients with ICU stay

    Time frame: throughout the study: 5 years

  5. Percentage of patients with continuing care

    Percentage of patients with continuing care after discharge from the ICU

    Time frame: throughout the study: 5 years

  6. Frequency of dialysis

    Frequency of dialysis

    Time frame: throughout the study: 5 years

07

Study locations

1 site
  • Emergency Department, Bichat-Claude Bernard Hospital
    Paris, Île-de-France 75018, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02307136
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Dec 4, 2014
Start date
Jan 2013
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Feb 17, 2016

Study contacts

Enrique CASALINO, MD, PhD
principal investigator · APHP

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion